Tissue Plasminogen Activator (TPA) therapy requires monitoring for excessive bleeding and neurological signs.
Tissue Plasminogen Activator (TPA) is a thrombolytic agent used to break down blood clots. After administering TPA, the nurse should prioritize monitoring for excessive bleeding for the first 8 hours to assess the effectiveness and potential side effects of the therapy. Additionally, the nurse should assess neurologic signs frequently throughout the course of therapy to monitor for any adverse neurological effects.
https://brainly.com/question/44062820